LifePoint Health Inc (LPNT) Receives $57.64 Consensus PT from Brokerages

Shares of LifePoint Health Inc (NASDAQ:LPNT) have earned an average recommendation of “Hold” from the twenty-two ratings firms that are presently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, fifteen have assigned a hold recommendation and five have issued a buy recommendation on the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $57.64.

LPNT has been the topic of several research reports. BMO Capital Markets initiated coverage on shares of LifePoint Health in a report on Monday, October 16th. They issued a “market perform” rating and a $59.00 price target on the stock. Raymond James Financial restated a “market perform” rating on shares of LifePoint Health in a report on Monday, October 30th. Robert W. Baird set a $55.00 price target on shares of LifePoint Health and gave the company a “buy” rating in a report on Monday, October 30th. SunTrust Banks set a $54.00 price target on shares of LifePoint Health and gave the company a “hold” rating in a report on Tuesday, October 31st. Finally, William Blair restated an “outperform” rating on shares of LifePoint Health in a report on Tuesday, November 21st.

In other news, insider David M. Dill sold 45,000 shares of LifePoint Health stock in a transaction that occurred on Tuesday, January 16th. The shares were sold at an average price of $48.52, for a total transaction of $2,183,400.00. Following the sale, the insider now owns 252,673 shares in the company, valued at $12,259,693.96. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Marguerite Kondracke sold 3,907 shares of LifePoint Health stock in a transaction that occurred on Tuesday, November 28th. The shares were sold at an average price of $44.73, for a total transaction of $174,760.11. The disclosure for this sale can be found here. Insiders have sold 52,323 shares of company stock worth $2,507,781 in the last quarter. Insiders own 8.76% of the company’s stock.

Several institutional investors and hedge funds have recently bought and sold shares of the company. Systematic Financial Management LP grew its position in shares of LifePoint Health by 24.8% during the fourth quarter. Systematic Financial Management LP now owns 32,229 shares of the company’s stock worth $1,605,000 after buying an additional 6,405 shares in the last quarter. Arizona State Retirement System grew its position in shares of LifePoint Health by 24.8% during the fourth quarter. Arizona State Retirement System now owns 28,368 shares of the company’s stock worth $1,413,000 after buying an additional 5,630 shares in the last quarter. The Manufacturers Life Insurance Company grew its position in shares of LifePoint Health by 11.1% during the fourth quarter. The Manufacturers Life Insurance Company now owns 65,248 shares of the company’s stock worth $3,249,000 after buying an additional 6,504 shares in the last quarter. Wells Fargo & Company MN grew its position in shares of LifePoint Health by 121.0% during the fourth quarter. Wells Fargo & Company MN now owns 79,235 shares of the company’s stock worth $3,946,000 after buying an additional 43,385 shares in the last quarter. Finally, First Trust Advisors LP grew its position in shares of LifePoint Health by 33.4% during the fourth quarter. First Trust Advisors LP now owns 414,248 shares of the company’s stock worth $20,630,000 after buying an additional 103,680 shares in the last quarter.

LifePoint Health (NASDAQ LPNT) traded up $0.70 during midday trading on Friday, reaching $47.55. 461,600 shares of the company traded hands, compared to its average volume of 526,126. LifePoint Health has a 52-week low of $42.50 and a 52-week high of $70.95. The company has a debt-to-equity ratio of 1.24, a current ratio of 1.85 and a quick ratio of 1.65. The stock has a market capitalization of $1,874.22, a price-to-earnings ratio of 11.24, a price-to-earnings-growth ratio of 1.09 and a beta of 0.52.

LifePoint Health announced that its board has initiated a share repurchase plan on Friday, October 27th that permits the company to buyback $200.00 million in outstanding shares. This buyback authorization permits the company to reacquire shares of its stock through open market purchases. Stock buyback plans are typically a sign that the company’s leadership believes its stock is undervalued.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally published by The Lincolnian Online and is owned by of The Lincolnian Online. If you are accessing this piece of content on another publication, it was illegally copied and republished in violation of US and international copyright laws. The original version of this piece of content can be read at https://www.thelincolnianonline.com/2018/02/12/lifepoint-health-inc-lpnt-receives-57-64-consensus-pt-from-brokerages.html.

About LifePoint Health

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.

Analyst Recommendations for LifePoint Health (NASDAQ:LPNT)

Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply